Heptabarb
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
5-cyclohept-1-en-1-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
Clinical data | |
Pregnancy category |
|
Legal status |
|
Routes of administration |
Oral[1] |
Pharmacokinetic data | |
Bioavailability | 83%[1] |
Metabolism | Hepatic |
Biological half-life | 6.1-11.2 hours[1] |
Excretion | Renal[1] |
Identifiers | |
CAS Number | 509-86-4 |
ATC code | N05CA11 (WHO) |
PubChem | CID: 10518 |
DrugBank | DB01354 |
ChemSpider | 10081 |
UNII | V10R70ML23 |
KEGG | C17725 |
ChEMBL | CHEMBL468837 |
Synonyms | G-475 |
Chemical data | |
Formula | C13H18N2O3 |
Molecular mass | 250.294 g/mol |
|
|
|
|
(verify) |
Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.[2][3] It was used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.[2][3]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>